|
| |
Amphora Discovery CorporationAmphora is a fully integrated drug discovery and development company. The company employs cutting-edge chemogenomic, systems biology and microfluidics technologies to develop innovative, targeted therapies for significant human diseases. Our primary mission is to improve patient care by rapidly developing proprietary human therapeutics that target the complex molecular causes of disease and to provide patients with treatment options that are more effective and better tolerated than currently available therapies. We strive to take drugs systematically from Database to IND in under two years. Amphora is committed to innovating first-in-class or best-in-class therapies for the treatment of cancer and other serious diseases where high unmet medical need exists.
| Contact Details: |
| PO Box 12169Research Triangle Park |
| Research Triangle Park |
| North Carolina |
| 27709-2169 |
| United States of America |
| Tel: | (919) 287 - 6200 |
| Fax: | (919) 806 - 3477 |
| Email: | |
| WWW: | www.amphoracorp.com/
|
|
Loading...
|
Recent Publications by Amphora Discovery Corporation: |  |
The use of diversity profiling to characterize chemical modulators of the histone deacetylases.
Target specificity and off-target liabilities are routinely monitored... | 1st July, 2008
| Amphora Discovery Corp., Research Triangle Park, Durham, NC 27713, USA.
| Life Sci. 2008 May 23;82(21-22):1050-8. Epub 2008 Mar 21.
DOI Direct Link |
A chemogenomic approach to discovering target-selective drugs.
An approach is described for identifying scaffolds with predefined... | 26th July, 2006
| Amphora Discovery Corporation, 800 Capitola Drive, Durham, NC 27713, USA.
| Chem Biol Drug Des. 2006 Jan;67(1):85-6.
DOI Direct Link |
Recent developments in focused library design: targeting gene-families.
For many years, the most frequently optimized qualities of a screening... | 3rd March, 2006
| Corporate Development, Amphora Discovery Corporation, 419 South San
| Curr Top Med Chem. 2006;6(1):19-29.
|
Discovery of highly selective inhibitors of p38alpha.
The p38 MAP kinases are a family of serine/threonine protein kinases that... | 27th January, 2006
| Amphora Discovery Corporation, P.O. Box 12169, Research Triangle Park, NC
| Curr Top Med Chem. 2005;5(10):941-51.
|
Streamlined system for purifying and quantifying a diverse library of compounds and the effect of compound concentration measurements on the accurate interpretation of biological assay results.
As part of an overall systems approach to generating highly accurate... | 23rd February, 2005
| Amphora Discovery Corporation, P.O. Box 12169, Research Triangle Park,
| Anal Chem. 2004 Dec 15;76(24):7278-87.
DOI Direct Link |
→View more Amphora Discovery Corporation research publications. |
Press Releases on Amphora Discovery Corporation:
|
 |
| Nanosyn Announces Opening of Its First Branch on the East Coast |
21st October, 2008 |
|
MENLO PARK, California, October 21 /PRNewswire/ -- Nanosyn announced today that it has acquired assets left from the ceased
operations of Amphora Discovery Corporation and opened its first branch on
|
 Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 1378 times since April 2007, the link to the organisation's website has been followed 394 times Recent Search Terms used to find this page: amphora corp | Amphora Discovery Corporation | Amphora Corporation | Amphora Discovery Corporation | human importance of Amphora | amphora rtp nc | amphora durham nc | amphora discovery corporation | amphora discovery corporation | Amphora Discovery Corporation | . Search for more companies in Research Triangle Park Search for more companies in North Carolina This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for Amphora Discovery Corporation |
